These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 33134121)

  • 81. Xpert MTB/RIF for rapid detection of rifampicin-resistant Mycobacterium tuberculosis from pulmonary tuberculosis patients in Southwest Ethiopia.
    Tadesse M; Aragaw D; Dimah B; Efa F; Abebe G
    Int J Mycobacteriol; 2016 Dec; 5 Suppl 1():S48-S49. PubMed ID: 28043605
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Performance evaluation of Xpert MTB/RIF in a moderate tuberculosis incidence compared with TaqMan MTB and TRCRapid M.TB.
    Tsuyuguchi K; Nagai H; Ogawa K; Matsumoto T; Morimoto K; Takaki A; Mitarai S
    J Infect Chemother; 2017 Feb; 23(2):101-106. PubMed ID: 27919693
    [TBL] [Abstract][Full Text] [Related]  

  • 83. The new Xpert Mycobacterium tuberculosis/rifampicin (MTB/Rif) Ultra assay in comparison to Xpert MTB/Rif assay for diagnosis of tuberculosis in children and adolescents.
    Kaur H; Guglani V; Singhal L; Randev S; Kumar P; Gupta V
    J Trop Pediatr; 2023 Dec; 70(1):. PubMed ID: 38116810
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Line probe assay test in new cases of tuberculosis with rifampicin resistance not detected by Xpert MTB/RIF.
    Soedarsono S; Mertaniasih NM; Hasan H; Kusmiati T; Permatasari A; Kusumaningrum D; Wijaksono W
    Int J Mycobacteriol; 2022; 11(4):429-434. PubMed ID: 36510930
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Contribution of medical colleges to tuberculosis control in India under the Revised National Tuberculosis Control Programme (RNTCP): lessons learnt & challenges ahead.
    Sharma SK; Mohan A; Chauhan LS; Narain JP; Kumar P; Behera D; Sachdeva KS; Kumar A; ; Agarwal P; Awadh NT; Bansal A; Baruah S; Baruwa P; Balasangameshwara VH; Balasubramanian R; Bhardwaj AK; Bhargav S; Chadha S; Chaddha VK; Chhatwal M; Da Costa AL; Dash DP; Dep J; Dhingra S; Dhooria Harmeet S; Frieden TR; Garg A; Granich R; Gulati V; Gupta D; Gupta D; Gupta KB; Gupta KN; Jaikishan ; Janmeja AK; Jawahar MS; Jethani SL; Jindal SK; John KR; Kalra OP; Kalra VP; Kannan AT; Kayshap S; Keshav Chander G; Khushwa SS; Kushwaha RS; Kumar V; Laskar B; Leela Itty Amma KR; Leuva AT; Maitra Malay K; Mesquita AM; Mathew T; Mundade Y; Munje R; Nagpal S; Nagaraja C; Nair S; Narayanan OR; Paramasivan CN; Parmar M; Prasad R; Phukan AC; Prasanna R; Purty A; Ramachandran R; Ramachandran R; Ravindran C; Reddy Raveendra HR; Sahu S; Santosha ; Sarin R; Sarkar S; Sarma KC; Saxena P; Sehgal S; Sharath N; Sharma G; Sharma N; Shridhar PK; Shukla RS; Singh O; Singh NT; Singh V; Singla R; Sinha N; Sinha P; Sinha S; Solanki R; Sreenivas A; Srinath S; Subhakar K; Suri JC; Talukdar P; Tonsing J; Tripathy SP; Vaidyanathan P; Vashist RP; Venu K
    Indian J Med Res; 2013 Feb; 137(2):283-94. PubMed ID: 23563371
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Multidrug Resistant Mycobacterium tuberculosis Among Military and Civilian Personnel seen at a Tertiary Military Hospital, Manila, Philippines (2015-2018).
    Velasco JM; Gaurano N; Valderama MT; Nogrado K; Diones PC; Lopez MN; Liao C; Chua D; Develos M; Fernandez S; Macareo L; Swierczewski B
    Mil Med; 2020 Aug; 185(7-8):e1106-e1111. PubMed ID: 31915831
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Low prevalence of MDR-TB in Lao PDR: results from the first national anti-tuberculosis drug resistance survey.
    Iem V; Dean A; Zignol M; Vongvichit P; Inthavong D; Siphanthong S; Sorsavanh T; Kim SJ; Shin S; Sébert J; Chittamany P
    Trop Med Int Health; 2019 Apr; 24(4):421-431. PubMed ID: 30663180
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Patients pathways to tuberculosis diagnosis and treatment in a fragmented health system: a qualitative study from a south Indian district.
    Yellappa V; Lefèvre P; Battaglioli T; Devadasan N; Van der Stuyft P
    BMC Public Health; 2017 Aug; 17(1):635. PubMed ID: 28778192
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Impact of Laboratory Practice Changes on the Diagnosis of Tuberculosis with the Introduction of Xpert MTB/RIF in Kiribati.
    Tonganibeia A; Harries AD; Merilles OEA; Tarataake T; Tiira T; Kienene T
    Hawaii J Med Public Health; 2018 Feb; 77(2):30-34. PubMed ID: 29435388
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Utility of Xpert MTB/RIF Assay for Diagnosis of Pediatric Tuberculosis Under Programmatic Conditions in India.
    Yadav R; Vaidya P; Mathew JL; Verma S; Khaneja R; Agarwal P; Kumar P; Singh M; Sethi S
    J Epidemiol Glob Health; 2020 Jun; 10(2):153-156. PubMed ID: 32538031
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Rifampicin-resistant
    Sah SK; Bhattarai PR; Shrestha A; Dhami D; Guruwacharya D; Shrestha R
    Infect Drug Resist; 2020; 13():2911-2919. PubMed ID: 32903905
    [TBL] [Abstract][Full Text] [Related]  

  • 92. A comparison of multidrug-resistant tuberculosis treatment commencement times in MDRTBPlus line probe assay and Xpert® MTB/RIF-based algorithms in a routine operational setting in Cape Town.
    Naidoo P; du Toit E; Dunbar R; Lombard C; Caldwell J; Detjen A; Squire SB; Enarson DA; Beyers N
    PLoS One; 2014; 9(7):e103328. PubMed ID: 25079599
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Diagnostic performance of GeneXpert MTB/RIF in detecting MTB in smear-negative presumptive TB patients.
    Rimal R; Shrestha D; Pyakurel S; Poudel R; Shrestha P; Rai KR; Ghimire GR; Rai G; Rai SK
    BMC Infect Dis; 2022 Apr; 22(1):321. PubMed ID: 35365080
    [TBL] [Abstract][Full Text] [Related]  

  • 94. [A study of the value of three molecular diagnostic techniques in the diagnosis of tuberculosis].
    Huang F; Dang L; Sun H; Yang H; Wu X
    Zhonghua Jie He He Hu Xi Za Zhi; 2015 Sep; 38(9):680-5. PubMed ID: 26703773
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Rapid and accurate detection of Mycobacterium tuberculosis in sputum samples by Cepheid Xpert MTB/RIF assay--a clinical validation study.
    Rachow A; Zumla A; Heinrich N; Rojas-Ponce G; Mtafya B; Reither K; Ntinginya EN; O'Grady J; Huggett J; Dheda K; Boehme C; Perkins M; Saathoff E; Hoelscher M
    PLoS One; 2011; 6(6):e20458. PubMed ID: 21738575
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Evaluation of Xpert MTB/RIF Assay, MTB Culture and Line Probe Assay for the Detection of MDR Tuberculosis in AFB Smear Negative Specimens.
    Lama C; Adhikari S; Sapkota S; Regmi RS; Ghimire GR; Banjara MR; Ghimire P; Rijal KR
    Diseases; 2022 Oct; 10(4):. PubMed ID: 36278581
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults.
    Steingart KR; Sohn H; Schiller I; Kloda LA; Boehme CC; Pai M; Dendukuri N
    Cochrane Database Syst Rev; 2013 Jan; (1):CD009593. PubMed ID: 23440842
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Utility of the REBA MTB-Rifa® assay for rapid detection of rifampicin resistant Mycobacterium tuberculosis.
    Cho E; Shamputa IC; Kwak HK; Lee J; Lee M; Hwang S; Jeon D; Kim CT; Cho S; Via LE; Barry CE; Lee JS
    BMC Infect Dis; 2013 Oct; 13():478. PubMed ID: 24128118
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Comparison of tests done, and tuberculosis cases detected by Xpert® MTB/RIF and Xpert® MTB/RIF-Ultra in Uganda.
    Kakinda M; Tugumisirize D; Nyombi A; Mugisha M; Turyahabwe S; Walusimbi S; Matovu JKB
    PLoS One; 2022; 17(10):e0275960. PubMed ID: 36215286
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Epidemiology of Rifampicin Resistant Tuberculosis and Common Mutations in rpoB Gene of Mycobacterium tuberculosis: A Retrospective Study from Six Districts of Punjab (India) Using Xpert MTB/RIF Assay.
    Kaur R; Jindal N; Arora S; Kataria S
    J Lab Physicians; 2016; 8(2):96-100. PubMed ID: 27365918
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.